60 related articles for article (PubMed ID: 9568786)
41. The cumulative effects of polymorphisms in the DNA mismatch repair genes and tobacco smoking in oesophageal cancer risk.
Vogelsang M; Wang Y; Veber N; Mwapagha LM; Parker MI
PLoS One; 2012; 7(5):e36962. PubMed ID: 22623965
[TBL] [Abstract][Full Text] [Related]
42. Reduced expression of DNA repair genes (XRCC1, XPD, and OGG1) in squamous cell carcinoma of head and neck in North India.
Kumar A; Pant MC; Singh HS; Khandelwal S
Tumour Biol; 2012 Feb; 33(1):111-9. PubMed ID: 22081374
[TBL] [Abstract][Full Text] [Related]
43. DNA repair phenotype and cancer susceptibility--a mini review.
Li C; Wang LE; Wei Q
Int J Cancer; 2009 Mar; 124(5):999-1007. PubMed ID: 19065660
[TBL] [Abstract][Full Text] [Related]
44. In vitro expression levels of cell-cycle checkpoint proteins are associated with cellular DNA repair capacity in peripheral blood lymphocytes: a multivariate analysis.
Fan YH; Hu Z; Li C; Wang LE; Guo Z; Qiao Y; Zhang L; Zhang W; Mao L; Wei Q
J Proteome Res; 2007 Apr; 6(4):1560-7. PubMed ID: 17362036
[TBL] [Abstract][Full Text] [Related]
45. Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients.
Park SY; Hong YC; Kim JH; Kwak SM; Cho JH; Lee HL; Ryu JS
Med Oncol; 2006; 23(4):489-98. PubMed ID: 17303907
[TBL] [Abstract][Full Text] [Related]
46. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.
Zienolddiny S; Ryberg D; Arab MO; Skaug V; Haugen A
Br J Cancer; 2001 Jan; 84(2):226-31. PubMed ID: 11161381
[TBL] [Abstract][Full Text] [Related]
47. Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair.
Fan CY
Curr Oncol Rep; 2001 Jan; 3(1):66-71. PubMed ID: 11123872
[TBL] [Abstract][Full Text] [Related]
48. Reduced expression of mismatch repair genes in colorectal cancer patients in Egypt.
Soliman AS; Bondy ML; Guan Y; El-Badawi S; Mokhtar N; Bayomi S; Raouf AA; Ismail S; McPherson RS; Abdel-Hakim TF; Beasley RP; Levin B; Wei Q
Int J Oncol; 1998 Jun; 12(6):1315-9. PubMed ID: 9592192
[TBL] [Abstract][Full Text] [Related]
49. Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control study.
Strom SS; Spitz MR; Yamamura Y; Babaian RJ; Scardino PT; Wei Q
Prostate; 2001 Jun; 47(4):269-75. PubMed ID: 11398174
[TBL] [Abstract][Full Text] [Related]
50. Reduced expression of human mismatch repair genes in adult T-cell leukemia.
Morimoto H; Tsukada J; Kominato Y; Tanaka Y
Am J Hematol; 2005 Feb; 78(2):100-7. PubMed ID: 15682421
[TBL] [Abstract][Full Text] [Related]
51. Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction.
Wei Q; Guan Y; Cheng L; Radinsky R; Bar-Eli M; Tsan R; Li L; Legerski RJ
Pathobiology; 1997; 65(6):293-300. PubMed ID: 9491849
[TBL] [Abstract][Full Text] [Related]
52. Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.
Wei Q; Bondy ML; Mao L; Gaun Y; Cheng L; Cunningham J; Fan Y; Bruner JM; Yung WK; Levin VA; Kyritsis AP
Cancer Res; 1997 May; 57(9):1673-7. PubMed ID: 9135006
[TBL] [Abstract][Full Text] [Related]
53. Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer.
Wei Q; Eicher SA; Guan Y; Cheng L; Xu J; Young LN; Saunders KC; Jiang H; Hong WK; Spitz MR; Strom SS
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):309-14. PubMed ID: 9568786
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
